CureVac N.V. (CVAC)
CureVac Statistics
Share Statistics
CureVac has 224.31M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 224.31M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 3.5% |
| Shares Floating | 93.63M |
| Failed to Deliver (FTD) Shares | 25.46K |
| FTD / Avg. Volume | 3.09% |
Short Selling Information
The latest short interest is 3.77M, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 3.77M |
| Short % of Shares Out | 1.68% |
| Short % of Float | 4.03% |
| Short Ratio (days to cover) | 3.21 |
Valuation Ratios
The PE ratio is -3.23 and the forward PE ratio is -8.07. CureVac's PEG ratio is 0.3.
| PE Ratio | -3.23 |
| Forward PE | -8.07 |
| PS Ratio | 15.62 |
| Forward PS | 4.3 |
| PB Ratio | 1.62 |
| P/FCF Ratio | -2.6 |
| PEG Ratio | 0.3 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for CureVac.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.57 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.18 |
| Debt / FCF | -0.13 |
| Interest Coverage | -109.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $53.81K |
| Profits Per Employee | $-260.43K |
| Employee Count | 999 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 5.01 |
Taxes
| Income Tax | 198K |
| Effective Tax Rate | -0.08% |
Stock Price Statistics
The stock price has increased by -1.37% in the last 52 weeks. The beta is 2.53, so CureVac's price volatility has been higher than the market average.
| Beta | 2.53 |
| 52-Week Price Change | -1.37% |
| 50-Day Moving Average | 3.31 |
| 200-Day Moving Average | 3.22 |
| Relative Strength Index (RSI) | 43.25 |
| Average Volume (20 Days) | 825.34K |
Income Statement
In the last 12 months, CureVac had revenue of 53.76M and earned -260.17M in profits. Earnings per share was -1.18.
| Revenue | 53.76M |
| Gross Profit | -70.61M |
| Operating Income | -274.21M |
| Net Income | -260.17M |
| EBITDA | -234.09M |
| EBIT | -257.48M |
| Earnings Per Share (EPS) | -1.18 |
Balance Sheet
The company has 402.45M in cash and 41.82M in debt, giving a net cash position of 360.63M.
| Cash & Cash Equivalents | 402.45M |
| Total Debt | 41.82M |
| Net Cash | 360.63M |
| Retained Earnings | -1.57B |
| Total Assets | 854.19M |
| Working Capital | 490.36M |
Cash Flow
In the last 12 months, operating cash flow was -267.89M and capital expenditures -55.2M, giving a free cash flow of -323.09M.
| Operating Cash Flow | -267.89M |
| Capital Expenditures | -55.2M |
| Free Cash Flow | -323.09M |
| FCF Per Share | -1.47 |
Margins
Gross margin is -131.34%, with operating and profit margins of -510.08% and -483.96%.
| Gross Margin | -131.34% |
| Operating Margin | -510.08% |
| Pretax Margin | -483.59% |
| Profit Margin | -483.96% |
| EBITDA Margin | -435.45% |
| EBIT Margin | -510.08% |
| FCF Margin | -601% |
Dividends & Yields
CVAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CVAC is $10, which is 248.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $10 |
| Price Target Difference | 248.4% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 2.41 |
| Piotroski F-Score | 7 |